Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

HealthDay News — On Tuesday, the US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

Marks was integral in the COVID-19 vaccine rollout, and his departure has sparked concerns about the politicization of health decisions.

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading this week, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...

Moderna (NASDAQ:MRNA – Get Free Report ... and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune ...

So far, the only mRNA vaccines to be approved by the FDA are the coronavirus vaccines produced by Pfizer-BioNTech and Moderna. Other mRNA vaccines are in various stages of development, including ...

Novel, effective vaccines to prevent the disease are, therefore, urgently needed.